Korean Drug Co. Ltd (014570) — Net Asset Quality Index
Korean Drug Co. Ltd (014570) has a Net Asset Quality Index of 85.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩95.05 Billion minus total liabilities of ₩14.01 Billion yields net assets of ₩81.04 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 014570 financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Korean Drug Co. Ltd Net Asset Quality Index Over Time (2014–2024)
This chart shows how Korean Drug Co. Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 85.3%, representing net assets of ₩81.04 Billion against total assets of ₩95.05 Billion KRW. See Korean Drug Co. Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Korean Drug Co. Ltd (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for Korean Drug Co. Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Korean Drug Co. Ltd (014570) market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 87.9% | ₩78.11 Billion | ₩88.89 Billion | ₩10.78 Billion | ▲ +1.9 pp |
| 2023 | 85.9% | ₩77.09 Billion | ₩89.71 Billion | ₩12.62 Billion | ▼ -3.7 pp |
| 2022 | 89.6% | ₩84.71 Billion | ₩94.52 Billion | ₩9.80 Billion | ▲ +3.1 pp |
| 2021 | 86.5% | ₩76.69 Billion | ₩88.61 Billion | ₩11.92 Billion | ▲ +1.5 pp |
| 2020 | 85.0% | ₩70.87 Billion | ₩83.34 Billion | ₩12.47 Billion | ▼ -0.7 pp |
| 2019 | 85.8% | ₩65.05 Billion | ₩75.85 Billion | ₩10.80 Billion | ▼ -0.3 pp |
| 2018 | 86.1% | ₩62.80 Billion | ₩72.96 Billion | ₩10.16 Billion | ▲ +0.8 pp |
| 2017 | 85.3% | ₩56.97 Billion | ₩66.79 Billion | ₩9.82 Billion | ▲ +0.7 pp |
| 2016 | 84.6% | ₩53.66 Billion | ₩63.41 Billion | ₩9.75 Billion | ▲ +0.7 pp |
| 2015 | 83.9% | ₩49.68 Billion | ₩59.20 Billion | ₩9.52 Billion | ▲ +5.4 pp |
| 2014 | 78.5% | ₩48.79 Billion | ₩62.17 Billion | ₩13.38 Billion | — |